Natural insomnia treatment statistics: the key numbers
Natural insomnia treatment statistics are mostly about CBT-I. A 2024 review pooled 9 trials. It estimated that 41% of adults starting with CBT-I were in remission, a satisfactory sleep score, at follow-up. About 28% starting with sleep medicine were. Fewer CBT-I starters dropped out. Magnesium and music studies are much smaller.
- 41% estimated remission at long-term follow-up for adults starting CBT-I, against about 28% for sleep medicine. (Furukawa et al., Psychiatry and Clinical Neurosciences, 2024 (DOI: 10.1111/pcn.13730))
- 21% estimated dropout by long-term follow-up with CBT-I, against about 39% with sleep medicine. (Furukawa et al., Psychiatry and Clinical Neurosciences, 2024 (DOI: 10.1111/pcn.13730))
- 4 to 8 sessions make up a usual CBT-I course in Australian patient information. (Sleep Health Foundation, Cognitive Behavioural Therapy for Insomnia (CBT-I), 2025)
- 17.36 minutes faster to fall asleep with magnesium than placebo in older adults, from 2 small trials. (Mah and Pitre, BMC Complementary Medicine and Therapies, 2021 (DOI: 10.1186/s12906-021-03297-z))
13 figures from 4 sources, data years 2021–2025, mostly North America and Europe. The full explanation is in our guide to natural insomnia treatment options, which separates recommended treatment from supportive habits.

These figures describe groups of people, not you personally. They’re for information, not medical advice.
How effective is drug-free insomnia treatment?
About 4 in 10 adults who started with CBT-I were estimated to be in remission at long-term follow-up. A 2024 review pooled 9 trials of 627 adults. Remission means a satisfactory score on a sleep scale. Adults who started with sleep medicine reached it about 28% of the time.
41% of adults who started with CBT-I were estimated to be in remission at long-term follow-up, compared with about 28% who started with sleep medicine.
40% of adults starting CBT-I plus sleep medicine were estimated to be in remission at long-term follow-up, against about 28% on medicine alone.
1.07 times the odds of remission at long-term follow-up with CBT-I alone as with CBT-I plus sleep medicine, which is no clear difference.
What this means for you: These are group averages, not a forecast for one person. Starting with CBT-I alone and starting with CBT-I plus medicine showed no clear difference, so a drug-free preference is a fair thing to raise. Our Article section on drug-free care alongside prescribed medicine shows how.
How much do treatments change insomnia severity and sleep time?
Right after treatment, 38% of adults who started with CBT-I were estimated to be in remission. About 28% of those who started with sleep medicine were. Insomnia severity scores were lower after CBT-I. On average, time awake after first falling asleep was 11 minutes shorter with CBT-I. Total sleep time was also 20 minutes shorter with CBT-I.
38% of adults starting CBT-I were estimated to be in remission when treatment ended, against about 28% starting sleep medicine.
−0.50 on a common scale: insomnia severity was lower after CBT-I than after sleep medicine.
11 minutes less time awake after first falling asleep, on average, with CBT-I than with sleep medicine.
20 minutes less total sleep time, on average, with CBT-I than with sleep medicine right after treatment.
What this means for you: Right after treatment, CBT-I did better on remission and severity, while sleep medicine gave more total sleep time. Those are different outcomes, so neither is a simple winner. Our CBT-I guide explains what the treatment involves.
How many people stop treatment early?
21% of adults who started with CBT-I were estimated to have dropped out by long-term follow-up. About 39% of those who started with sleep medicine had. Right after treatment, the estimates were 8% and about 16%. Researchers use dropout as a rough sign of how well people can stay with a treatment.
21% of adults who started with CBT-I were estimated to have dropped out by long-term follow-up, compared with about 39% who started with sleep medicine.
8% of adults who started with CBT-I were estimated to drop out before treatment ended, compared with about 16% who started with sleep medicine.
What this means for you: Dropout counts people who left for any reason, so it is only a rough sign of how easy a treatment is to stay with. Every CBT-I program in this review was run by a therapist, so apps may differ. Our Article section on reviewing progress shows what to check when an approach isn’t helping.
How many sessions does CBT-I usually take?
4 to 8 sessions is the usual CBT-I course in an Australian patient fact sheet. That describes treatment length, not how soon sleep improves. Programs differ by provider and format. In the 2024 review, end-of-treatment results were measured after a median of 8 weeks.
4 to 8 sessions make up a usual CBT-I course in Australian patient information.
What this means for you: A session count tells you about time and effort, not about when sleep will change. Providers set their own schedules. Our Article section on finding treatment lists routes in the US, UK, Canada and Australia, with coverage checks.
What do the numbers show for magnesium and music?
Magnesium users fell asleep 17.36 minutes faster than placebo users on average. That came from 2 trials of 55 older adults. For music, sleep quality scores were 2.79 points better across 10 studies of 708 adults. Certainty was low for magnesium and moderate for that music result.
17.36 minutes faster to fall asleep, on average, with magnesium than with placebo in older adults with insomnia.
2.79 points lower on a sleep quality score after listening to music than with no music or usual care.
6.96 points lower on an insomnia severity score with music in 2 small studies, though the range includes no difference.
What this means for you: These small studies describe how fast people fell asleep or how sleep felt, not whether insomnia went away. The music result for insomnia severity came from 2 small studies, and its range included no difference. Our Answers page takes each ingredient question one at a time, including safety and medicine interactions.
Natural insomnia treatment statistics table
| What it measures | Figure | Who / based on | Compared with · when | Source |
|---|---|---|---|---|
| Remission at long-term follow-up, CBT-I first | 41%, estimated from an odds ratio of 1.82 (95% CI 1.15 to 2.87), estimated range 31% to 53% | Adults with chronic insomnia not taking sleep medicine, mostly North America and Europe · 9 trials, 627 adults | Sleep medicine first (about 28%) · 12 to 48 weeks, median 24 · published 2024 | Furukawa et al., Psychiatry and Clinical Neurosciences, 2024 (DOI: 10.1111/pcn.13730) |
| Remission at long-term follow-up, CBT-I plus sleep medicine first | 40%, estimated from an odds ratio of 1.71 (95% CI 0.88 to 3.30), estimated range 25% to 56% | Same adults · 5 combination arms, 142 adults | Sleep medicine first (about 28%) · long-term follow-up · published 2024 | Furukawa et al., Psychiatry and Clinical Neurosciences, 2024 (DOI: 10.1111/pcn.13730) |
| Odds of remission, CBT-I alone versus CBT-I plus sleep medicine | Odds ratio 1.07 (95% CI 0.63 to 1.80) | Same adults · 9 CBT-I arms, 292 adults · 5 combination arms, 142 adults | CBT-I plus sleep medicine · long-term follow-up · published 2024 | Furukawa et al., Psychiatry and Clinical Neurosciences, 2024 (DOI: 10.1111/pcn.13730) |
| Remission when treatment ended, CBT-I first | 38%, estimated from an odds ratio of 1.58 (95% CI 1.07 to 2.35), estimated range 29% to 48% | Same adults · 13 trials, 823 adults overall | Sleep medicine first (about 28%) · end of treatment, median 8 weeks · published 2024 | Furukawa et al., Psychiatry and Clinical Neurosciences, 2024 (DOI: 10.1111/pcn.13730) |
| Insomnia severity after treatment | −0.50, standardized mean difference (95% CI −0.86 to −0.15) | Same adults · 13 trials, 823 adults overall | Sleep medicine · end of treatment · published 2024 | Furukawa et al., Psychiatry and Clinical Neurosciences, 2024 (DOI: 10.1111/pcn.13730) |
| Time awake after first falling asleep | −11 minutes, mean difference (95% CI −18 to −3) | Same adults · 13 trials, 823 adults overall | Sleep medicine · end of treatment · published 2024 | Furukawa et al., Psychiatry and Clinical Neurosciences, 2024 (DOI: 10.1111/pcn.13730) |
| Total sleep time | −20 minutes, mean difference (95% CI −39 to −2) | Same adults · 13 trials, 823 adults overall | Sleep medicine · end of treatment, gap unclear at long-term follow-up · published 2024 | Furukawa et al., Psychiatry and Clinical Neurosciences, 2024 (DOI: 10.1111/pcn.13730) |
| Dropout by long-term follow-up | 21%, estimated from an odds ratio of 0.42 (95% CI 0.26 to 0.66), estimated range 14% to 30% | Same adults · long-term analysis (9 trials, 627 adults for remission) | Sleep medicine first (about 39%) · 12 to 48 weeks · published 2024 | Furukawa et al., Psychiatry and Clinical Neurosciences, 2024 (DOI: 10.1111/pcn.13730) |
| Dropout before treatment ended | 8%, estimated from an odds ratio of 0.47 (95% CI 0.27 to 0.83), estimated range 5% to 14% | Same adults · 13 trials, 823 adults overall | Sleep medicine first (about 16%) · end of treatment · published 2024 | Furukawa et al., Psychiatry and Clinical Neurosciences, 2024 (DOI: 10.1111/pcn.13730) |
| Usual length of a CBT-I course | 4 to 8 sessions, descriptive range | People having CBT-I, Australia · N/A, service guidance rather than a trial | No comparison · whole treatment course · published 2025 | Sleep Health Foundation, Cognitive Behavioural Therapy for Insomnia (CBT-I), 2025 |
| Time to fall asleep with magnesium | −17.36 minutes, pooled mean difference (95% CI −27.27 to −7.44) | Older adults with insomnia · 2 trials, 55 adults | Placebo · 20 days to 8 weeks · review published 2021 | Mah and Pitre, BMC Complementary Medicine and Therapies, 2021 (DOI: 10.1186/s12906-021-03297-z) |
| Sleep quality score with music | −2.79 PSQI points, pooled mean difference (95% CI −3.86 to −1.72) | Adults reporting sleep difficulties · 10 studies, 708 adults | No intervention or usual care · end of intervention, 3 days to 3 months · review published 2022 | Jespersen et al., Cochrane Database of Systematic Reviews, 2022 (DOI: 10.1002/14651858.CD010459.pub3) |
| Insomnia severity score with music | −6.96 ISI points, pooled mean difference (95% CI −15.21 to 1.28) | Adults reporting sleep difficulties · 2 studies, 63 adults | No treatment or usual care · end of intervention · review published 2022 | Jespersen et al., Cochrane Database of Systematic Reviews, 2022 (DOI: 10.1002/14651858.CD010459.pub3) |
Why do treatment statistics disagree?
The 41% and 38% remission figures look close but answer different questions. One is at long-term follow-up, 12 to 48 weeks in. The other is at the end of treatment, a median of 8 weeks in. Both were estimated by applying an odds ratio to the same 28% reference rate from sleep medicine arms. Use 41% for how people are doing months later. Use 38% for how they are doing when treatment ends.
CBT-I led on remission, dropouts and insomnia severity. Yet total sleep time was 20 minutes shorter right after treatment. These are different outcomes. A treatment can lead on one and trail on another. Which one matters most depends on what you want from your sleep.
Magnesium and music show the same split. The magnesium review found people fell asleep 17.36 minutes faster. Its change in total sleep time could not be told apart from no change. The music review found better sleep quality scores across 10 studies. Only 2 small studies measured insomnia severity. A result for sleep quality or falling asleep cannot stand in for remission or insomnia severity. That is why this page has no single chart ranking treatments.
What the numbers can’t tell you
Remission is defined by a score cut-off, and cut-offs differ between trials. The 2024 review accepted several sleep scales. When a trial did not report remitters, the authors estimated them with a standard method. Most results here are self-reported, so they show how sleep felt rather than lab-measured sleep.
Who is missing matters too. Every CBT-I program in that review was run by a therapist, so it gives no figure for apps or books. Most trials took place in North America and Europe. People who join trials are often highly motivated. Only one trial gave its comparison group a sleep-information placebo. One author of that review teaches CBT-I and writes CBT-I manuals.
Some families of numbers are empty here. We hold no figure we could confirm for how many people use natural options, what treatment costs, or how long results last beyond 48 weeks. Exercise and melatonin have review figures, but we could not confirm how many people each outcome was based on, so we left them out. For mindfulness, valerian, chamomile and ashwagandha we hold no confirmed figure.
These natural insomnia treatment statistics describe groups, not you. A group average can’t predict your own sleep, and a gap between treatments is not a before-and-after promise. If you want to turn these numbers into appointment questions, our treatment discussion planner builds printable notes for you.
How we compiled this page: we gathered figures from the published studies and official sources below, recorded each figure’s outcome, population, comparison, timepoint and year exactly as published, and ran no surveys of our own. The original figures belong to their publishers. Our compilation and wording may be reused with credit under CC BY 4.0.
Turn the numbers into your next step
See how each option connects on our natural insomnia treatment mind map. Ready to act? Our Compass helps you pick a next step. More in Sleep Disorders.
See how it all connects →Sources
- Psychiatry and Clinical Neurosciences — Initial treatment choices for long-term remission of chronic insomnia disorder in adults: a systematic review and network meta-analysis (2024) — systematic review and network meta-analysis; used for: remission, dropouts, insomnia severity, night waking and total sleep time for CBT-I compared with sleep medicine
- BMC Complementary Medicine and Therapies — Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis (2021) — systematic review and meta-analysis; used for: how much faster older adults fell asleep with magnesium
- Cochrane Database of Systematic Reviews — Listening to music for insomnia in adults (2022) — systematic review; used for: sleep quality and insomnia severity scores with music
- Sleep Health Foundation — Cognitive Behavioural Therapy for Insomnia (CBT-I) (2025) — national sleep-health fact sheet; used for: the usual number of CBT-I sessions
Figures checked · 13 figures from 4 sources · Next review
How we made this page: figures gathered and checked from the sources above, written up with AI assistance and edited by Aamir Bashir, Founder & Editor. Read our editorial policy.